Smad interacting protein 1 influences transforming growth factor-β1/Smad signaling in extracellular matrix protein production and hypertrophic scar formation

被引:31
作者
Fang, Xiaobing [1 ]
Hu, Xiaolong [1 ]
Zheng, Zhao [1 ]
Tao, Ke [1 ]
Wang, Hongtao [1 ]
Guan, Hao [1 ]
Shi, Jihong [1 ]
Ji, Peng [1 ]
Cai, Weixia [1 ]
Bai, Xiaozhi [1 ]
Zhu, Xiongxiang [1 ]
Han, Juntao [1 ]
Liu, Jiaqi [1 ]
Hu, Dahai [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Fibrosis; Hypertrophic scar; Smad; Smad interacting protein 1; Transforming growth factor-beta(1); FACTOR-BETA; COLLAGEN EXPRESSION; III COLLAGEN; FIBROBLASTS; FIBROSIS; MYOFIBROBLAST; MICRORNA-192; CONTRACTION; MECHANISMS; INHIBITION;
D O I
10.1007/s10735-019-09844-w
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The transforming growth factor (TGF)-beta/Smad signal transduction pathway is closely associated with hypertrophic scar (HS) formation. Smad interacting protein 1 (SIP1) is a cytoplasmic protein that efficiently regulates Smad2-/3-dependent signaling within the TGF-beta(1) pathway. SIP1 influences collagen synthesis in the HS through a heretofore unknown mechanism. This study investigated the role of the SIP1-mediated TGF-beta(1)/Smad signaling pathway in extracellular matrix (ECM) protein production and hypertrophic scarring. SIP1 expression was markedly lower in HS vs. normal skin (NS) tissue, and alpha-smooth muscle actin (alpha-SMA) content and collagen I/III (Col I/III) synthesis were inversely correlated with SIP1 expression. Furthermore, SIP1 inhibited Smad2/3 phosphorylation in vitro, and improved the collagen-based architecture of the scar while reducing collagen expression and overall scar formation in a rabbit ear model of HS. Based on these findings, we propose that SIP1 acts as a molecular modulator capable of altering Smad2-/3-facilitated signaling through the control of Smad phosphorylation, thus inhibiting alpha-SMA and collagen upregulation in fibroblasts and, ultimately, HS formation. The low SIP1 content in scar tissue also suggests that SIP1 (and positive regulation thereof) is a prospective target for selective HS drug therapy.
引用
收藏
页码:503 / 514
页数:12
相关论文
共 55 条
[1]   Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response [J].
Ashcroft, GS ;
Yang, X ;
Glick, AB ;
Weinstein, M ;
Letterio, JJ ;
Mizel, DE ;
Anzano, M ;
Greenwell-Wild, T ;
Wahl, SM ;
Deng, CX ;
Roberts, AB .
NATURE CELL BIOLOGY, 1999, 1 (05) :260-266
[2]   Quality of life of patients with keloid and hypertrophic scarring [J].
Bock, O ;
Schmid-Ott, G ;
Malewski, P ;
Mrowietz, U .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2006, 297 (10) :433-438
[3]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[4]   REQUIREMENTS FOR TRANSFORMING GROWTH-FACTOR-BETA REGULATION OF THE PRO-ALPHA-2(I) COLLAGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTERS [J].
CHANG, E ;
GOLDBERG, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) :4473-4477
[5]  
Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.3.CO
[6]  
2-F
[7]   TGF-β-induced fibrosis and SMAD signaling:: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring [J].
Cutroneo, Kenneth R. .
WOUND REPAIR AND REGENERATION, 2007, 15 :S54-S60
[8]   Tissue repair, contraction, and the myofibroblast [J].
Desmoulière, A ;
Chaponnier, C ;
Gabbiani, G .
WOUND REPAIR AND REGENERATION, 2005, 13 (01) :7-12
[9]   Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts [J].
Diao, Jian-Sheng ;
Xia, Wen-Sen ;
Yi, Cheng-Gang ;
Wang, Ying-Mei ;
Li, Bing ;
Xia, Wei ;
Liu, Bei ;
Guo, Shu-Zhong ;
Sun, Xu-De .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2011, 303 (08) :573-580
[10]   Snail, slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma [J].
Elloul, S ;
Elstrand, MB ;
Nesland, JM ;
Tropé, CG ;
Kvalheim, G ;
Goldberg, I ;
Reich, R ;
Davidson, B .
CANCER, 2005, 103 (08) :1631-1643